A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a...
Read moreReservoirs of pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for slow, concentrated delivery...
Read moreAstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused...
Read moreNovartis announced results from the head-to-head Phase III FIXTURE study showing secukinumab (AIN457), an interleukin-17A (IL-17A) inhibitor, was significantly superior...
Read moreNovartis and Malaria No More announced today the debut of the Power of One campaign, encouraging people around the world...
Read moreGlaxoSmithKline (GSK) plc has announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part...
Read moreNovartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the...
Read moreThe European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer...
Read moreNovartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on...
Read moreNovartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
